2,085
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Cognitive and affective determinants of generic drug acceptance and use: cross-sectional and experimental findings

&
Pages 5-14 | Received 14 Feb 2013, Accepted 30 Apr 2013, Published online: 11 Jun 2013

References

  • Al-Gedadi, N. A., Hassali, M. A., & Shafie, A. A. (2008). A pilot survey on perceptions and knowledge of generic medicines among consumers in Penang, Malaysia. Pharmacy Practice, 6(2), 93–97. doi:10.4321/S1886-36552008000200006
  • Alhakami, A. S., & Slovic, P. (1994). A psychological study of the inverse relationship between perceived risk and perceived benefit. Risk Analysis, 14(6), 1085–1096. doi: 10.1111/j.1539-6924.1994.tb00080.x
  • Benthin, A., Slovic, P., Moran, P., Severson, H., Mertz, C. K., & Gerrard, M. (1995). Adolescent health-threatening and health-enhancing behaviors – A study of word-association and imagery. Journal of Adolescent Health, 17(3), 143–152. doi: 10.1016/1054-139X(95)00111-5
  • Betsch, C., Renkewitz, F., Betsch, T., & Ulshofer, C. (2010). The influence of vaccine-critical websites on perceiving vaccination risks. Journal of Health Psychology, 15(3), 446–455. doi: 10.1177/1359105309353647
  • Chapman, G. B., & Coups, E. J. (2006). Emotions and preventive health behavior: Worry, regret, and influenza vaccination. Health Psychology, 25(1), 82–90. doi: 10.1037/0278-6133.25.1.82
  • Connor, M., & Siegrist, M. (2011). The power of association: Its impact on willingness to buy GM food. Human and Ecological Risk Assessment, 17(5), 1142–1155. doi: 10.1080/10807039.2011.605725
  • Cousin, M. E., & Siegrist, M. (2008). Laypeople's health concerns and health beliefs in regard to risk perception of mobile communication. Human and Ecological Risk Assessment, 14(6), 1235–1249. doi: 10.1080/10807030802494550
  • Decollogny, A., Eggli, Y., Halfon, P., & Lufkin, T. M. (2011). Determinants of generic drug substitution in Switzerland. BMC Health Services Research, 11. Art. no. 17. doi:10.1186/1472-6963-11-17 doi: 10.1186/1472-6963-11-17
  • Diefenbach, M. A., Miller, S. M., & Daly, M. B. (1999). Specific worry about breast cancer predicts mammography use in women at risk for breast and ovarian cancer. Health Psychology, 18(5), 532–536. doi: 10.1037/0278-6133.18.5.532
  • Dohle, S., Keller, C., & Siegrist, M. (2012). Mobile communication in the public mind: Insights from free associations related to mobile phone base stations. Human and Ecological Risk Assessment, 18(3), 649–668. doi: 10.1080/10807039.2012.672900
  • FDA. (2013). What are generic drugs? Retrieved January 31, 2013, from http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/UnderstandingGenericDrugs/ucm144456.htm
  • Figueiras, M. J., Alves, N. C., Marcelino, D., Cortes, M. A., Weinman, J., & Horne, R. (2009). Assessing lay beliefs about generic medicines: Development of the generic medicines scale. Psychology, Health & Medicine, 14(3), 311–321. doi: 10.1080/13548500802613043
  • Figueiras, M. J., Cortes, M. A., Marcelino, D., & Weinman, J. (2010). Lay views about medicines: The influence of the illness label for the use of generic versus brand. Psychology & Health, 25(9), 1121–1128. doi: 10.1080/08870440903137170
  • Figueiras, M. J., Marcelino, D., & Cortes, M. A. (2008). People's views on the level of agreement of generic medicines for different illnesses. Pharmacy World & Science, 30(5), 590–594. doi: 10.1007/s11096-008-9247-y
  • Finucane, M. L., Alhakami, A., Slovic, P., & Johnson, S. M. (2000). The affect heuristic in judgments of risks and benefits. Journal of Behavioral Decision Making, 13(1), 1–17. doi: 10.1002/(SICI)1099-0771(200001/03)13:1<1::AID-BDM333>3.0.CO;2-S
  • Finucane, M. L., Slovic, P., & Mertz, C. K. (2000). Public perception of the risk of blood transfusion. Transfusion, 40(8), 1017–1022. doi: 10.1046/j.1537-2995.2000.40081017.x
  • Fiske, A. P., & Tetlock, P. E. (1997). Taboo trade-offs: Reactions to transactions that transgress the spheres of justice. Political Psychology, 18(2), 255–297. doi: 10.1111/0162-895X.00058
  • Gaither, C., Kirking, D., Ascione, F., & Welage, L. (2001). Consumers’ view on generic medications. Journal of American Pharmaceutical Association, 41, 729–736.
  • Gill, L., Helkkula, A., Cobelli, N., & White, L. (2010). How do customers and pharmacists experience generic substitution? International Journal of Pharmaceutical and Healthcare Marketing, 4(4), 375–395. doi:10.1108/17506121011095218
  • Gillespie, M., Tenvergert, E. M., & Kingma, J. (1987). Using Mokken scale analysis to develop unidimensional scales. Quality & Quantity, 21(4), 393–408. doi:10.1007/BF00172565
  • Granlund, D. (2009). Are private physicians more likely to veto generic substitution of prescribed pharmaceuticals? Social Science & Medicine, 69(11), 1643–1650. doi: 10.1016/j.socscimed.2009.09.016
  • Hall, S., French, D. P., & Marteau, T. M. (2009). Do perceptions of vulnerability and worry mediate the effects of a smoking cessation intervention for women attending for a routine cervical smear test? An experimental study. Health Psychology, 28(2), 258–263. doi: 10.1037/a0013425
  • Hanneman, R. A., & Riddle, M. (2005). Introduction to social network methods. Riverside, CA: University of California, Riverside.
  • Hanselmann, M., & Tanner, C. (2008). Taboos and conflicts in decision making: Sacred values, decision difficulty, and emotions. Judgment and Decision Making, 3(1), 51–63.
  • Hassali, M. A., Kong, D. C. M., & Stewart, K. (2005). Generic medicines: Perceptions of consumers in Melbourne, Australia. International Journal of Pharmacy Practice, 13, 257–264. doi: 10.1211/ijpp.13.4.0004
  • Hassali, M. A., Shafie, A. A., Jamshed, S., Ibrahim, M. I., & Awaisu, A. (2009). Consumers’ views on generic medicines: A review of the literature. International Journal of Pharmacy Practice, 17(2), 79–88. doi:10.1211/ijpp.17.02.0002
  • Hay, J. L., McCaul, K. D., & Magnan, R. E. (2006). Does worry about breast cancer predict screening behaviors? A meta-analysis of the prospective evidence. Preventive Medicine, 42(6), 401–408. doi: 10.1016/j.ypmed.2006.03.002
  • Himmel, W., Simmenroth-Nayda, A., Niebling, W., Ledig, T., Jansen, R. D., Kochen, M. M., … Hummers-Pradier, E. (2005). What do primary care patients think about generic drugs? International Journal of Clinical Pharmacology and Therapeutics, 43(10), 472–479.
  • Keller, C., Visschers, V., & Siegrist, M. (2012a). Affective imagery and acceptance of replacing nuclear power plants. Risk Analysis, 32(3), 464–477. doi: 10.1111/j.1539-6924.2011.01691.x
  • Keller, C., Visschers, V., & Siegrist, M. (2012b). The content and not only the valence of spontaneous associations should be analyzed response. Risk Analysis, 32(3), 481–482. doi: 10.1111/j.1539-6924.2012.01794.x
  • Leiserowitz, A. (2005). American risk perceptions: Is climate change dangerous? Risk Analysis, 25(6), 1433–1442. doi: 10.1111/j.1540-6261.2005.00690.x
  • McCaul, K. D., Schroeder, D. M., & Reid, P. A. (1996). Breast cancer worry and screening: Some prospective data. Health Psychology, 15(6), 430–433. doi: 10.1037/0278-6133.15.6.430
  • Mokken, R. J., & Lewis, C. (1982). A nonparametric approach to the analysis of dichotomous item responses. Applied Psychological Measurement, 6(4), 417–430. doi: 10.1177/014662168200600404
  • OECD. (2011). Health at a glance 2011: OECD indicators. Paris: OECD Publishing.
  • OECD/WHO. (2011). Reviews of health systems: Switzerland 2011. Paris: OECD Publishing.
  • Panzer, M., & Renner, B. (2009). Spontaneous reactions to health risk feedback: A network perspective. Journal of Behavioral Medicine, 32(4), 317–327. doi: 10.1007/s10865-009-9206-7
  • Paris, V., & Docteur, E. (2007). Pharmaceutical pricing and reimbursement policies in Switzerland. OECD Health Working Papers, 27, 1–60. doi:10.1787/136157357151
  • Pereira, J. A., Holbrook, A. M., Dolovich, L., Goldsmith, C., Thabane, L., Douketis, J. D., … Ginsberg, J. S. (2005). Are brand-name and generic warfarin interchangeable? A survey of Ontario patients and physicians. The Canadian Journal of Clinical Pharmacology, 12(3), e229–239.
  • Schwartz, M. D., Peshkin, B. N., Valdimarsdottir, H., Tercyak, K. P., & Taylor, K. L. (2005). Decision making and decision support for hereditary breast-ovarian cancer susceptibility. Health Psychology, 24(4), S78–S84. doi: 10.1037/0278-6133.24.4.S78
  • Shrank, W. H., Cadarette, S. M., Cox, E., Fischer, M. A., Mehta, J., Brookhart, A. M., … Choudhry, N. K. (2009). Is there a relationship between patient beliefs or communication about generic drugs and medication utilization? Medical Care, 47(3), 319–325.
  • Shrank, W. H., Cox, E. R., Fischer, M. A., Mehta, J., & Choudhry, N. K. (2009). Patients’ perceptions of generic medications. Health Affairs, 28(2), 546–556. doi: 10.1377/hlthaff.28.2.546
  • Slovic, P., Finucane, M. L., Peters, E., & MacGregor, D. G. (2002). The affect heuristic. In T. Gilovich, D. Griffin, & D. Kahneman (Eds.), Heuristics and biases: The psychology of intuitive judgment (pp. 397–420). New York, NY: Cambridge University Press.
  • Slovic, P., Peters, E., Finucane, M. L., & MacGregor, D. G. (2005). Affect, risk, and decision making. Health Psychology, 24(4), S35–S40. doi: 10.1037/0278-6133.24.4.S35
  • Tanner, C., Ryf, B., & Hanselmann, M. (2009). Geschützte Werte Skala (GWS): Konstruktion und Validierung eines Messinstrumentes [Sacred value measure (SVM): Construction and validation of an instrument to assess sacred values]. Diagnostica, 55(3), 174–183. doi: 10.1026/0012-1924.55.3.174
  • Tetlock, P. E. (2003). Thinking the unthinkable: Sacred values and taboo cognitions. Trends in Cognitive Sciences, 7(7), 320–324. doi: 10.1016/S1364-6613(03)00135-9
  • Watson, R. (2006). Health spending rising faster than GDP in most rich countries. British Medical Journal, 333(7558), 60. doi: 10.1136/bmj.333.7558.60-a